The high prevalence of TP53 mutations in hereditary [20] and sporadic [38] ovarian carcinomas suggests that this gene is a frequent mutational target of the selective pressure for aneuploid cells to overcome this checkpoint. This evidence concerns the gene TP53 and ovarian carcinoma.